Skandinaviska Enskilda Banken (SEB)
GBT

Skandinaviska Enskilda Banken (SEB)’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,000
Closed -$1.02M – 939
2022
Q3 		$1.02M Buy
+15,000
New +$827K 0.01% 677

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s GBT Position: Q4 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 15,000 shares — an estimated $1.02M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $1.02M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 15,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.02M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Global Blood Therapeutics, Inc. position peaked at $1.02M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2022, filed 8 Feb 2023.